Galapagos NV Reports Strong Q1 2024 Financials
Company Announcements

Galapagos NV Reports Strong Q1 2024 Financials

Galapagos NV (GLPG) has released an update.

Galapagos NV shared positive first quarter financial results for 2024, with net revenues rising to €62.4 million, a 7% increase from the previous year, and a significant turnaround to a net profit from continuing operations of €23.5 million. The company has streamlined its operations by transferring its Jyseleca business to Alfasigma and is focusing on expanding its R&D pipeline through strategic collaborations and investments in oncology and immunology. Galapagos is maintaining its cash burn guidance and actively pursuing business development opportunities to strengthen its market position.

For further insights into GLPG stock, check out TipRanks’ Stock Analysis page.

Related Articles
TheFlyGalapagos to present data on CAR T-cell therapy candidates GLPG5101 and GLPG5201
TheFlyGalapagos price target lowered to EUR 28 from EUR 30 at Deutsche Bank
TipRanks Auto-Generated NewsdeskGalapagos NV Sees Pipeline Growth Amid Financial Challenges
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App